Page last updated: 2024-09-04

atazanavir sulfate and End Stage Liver Disease

atazanavir sulfate has been researched along with End Stage Liver Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Casado, JL; Dronda, F; Hermida, JM; Hernandez-Novoa, B; Moreno, A; Moreno, S; Perez-Elias, MJ; Quereda, C; Rodriguez, JM; Rodriguez, MA	1

Other Studies

1 other study(ies) available for atazanavir sulfate and End Stage Liver Disease

Article	Year
The use of atazanavir in HIV-infected patients with liver cirrhosis: lack of hepatotoxicity and no significant changes in bilirubin values or model for end-stage liver disease score. AIDS (London, England), 2011, Apr-24, Volume: 25, Issue:7 Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Bilirubin; End Stage Liver Disease; Female; HIV Infections; HIV-1; Humans; Liver Cirrhosis; Male; Oligopeptides; Pyridines	2011

Article

Year

The use of atazanavir in HIV-infected patients with liver cirrhosis: lack of hepatotoxicity and no significant changes in bilirubin values or model for end-stage liver disease score.

AIDS (London, England), 2011, Apr-24, Volume: 25, Issue:7

Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Bilirubin; End Stage Liver Disease; Female; HIV Infections; HIV-1; Humans; Liver Cirrhosis; Male; Oligopeptides; Pyridines

2011